Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mian Xi

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Cancer Medicine|June 16, 2023
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)XinLei Ai, PengXin Zhang, XinMin Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Annals of Surgery|June 20, 2017
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal AdenocarcinomaMian Xi, Christopher L Hallemeier, Kenneth W Merrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2026
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)Baoqing Chen, Shiliang Liu, Yujia Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional AnalysisMian Xi, Cai Xu, Zhongxing Liao, et al.
The Lancet. Respiratory Medicine|September 21, 2024
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trialZe-Rui Zhao, Shi-Liang Liu, Ting Zhou, et al.
Cancer Discovery|March 2, 2026
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer ChemoimmunotherapyZheng-Yu Qian, Yuqing Deng, Mian Xi, et al.
Cancer Communications (London, England)|October 30, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNAHui-Yan Luo, Wei Wei, Pansong Li, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Cancer Medicine|June 16, 2023
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)XinLei Ai, PengXin Zhang, XinMin Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Annals of Surgery|June 20, 2017
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal AdenocarcinomaMian Xi, Christopher L Hallemeier, Kenneth W Merrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2026
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)Baoqing Chen, Shiliang Liu, Yujia Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional AnalysisMian Xi, Cai Xu, Zhongxing Liao, et al.
The Lancet. Respiratory Medicine|September 21, 2024
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trialZe-Rui Zhao, Shi-Liang Liu, Ting Zhou, et al.
Cancer Discovery|March 2, 2026
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer ChemoimmunotherapyZheng-Yu Qian, Yuqing Deng, Mian Xi, et al.
Cancer Communications (London, England)|October 30, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNAHui-Yan Luo, Wei Wei, Pansong Li, et al.
Pageof 11